anticancer

Signed a technology export contract of 1.2 trillion won for Genexine immune anticancer drug candidate

INNON and Voronoi to develop global anticancer drug… Global clinical goals for 2022

HK Innoen in partnership with Voronoi will challenge global anticancer drug next year

Inoen introduces new anticancer drugs from Voronoi

Inno.N and Voronoi start global anticancer drug development

The anticancer drug of 7-year investment dream of Green Cross fruited… 2 trillion won exports to the US

[단독] Green Cross Labcell’s anticancer drug exports technology to Merck, USA… Total KRW 2 trillion

Developing anticancer drugs that catch 癌 mutations in cooperation with Flat Bio Bio

The 31st domestic new drug Yuhan Corporation’s anticancer drug’Lecra Jajeong’ license

The 31st domestic new drug Yuhan Corporation’s anticancer drug’Lecra Jajeong’ license

Genome & Company “The world’s first discovery of microbiome strains with anticancer efficacy… Patent pending”

Naivek Participates in JP Morgan Healthcare… Announces Anticancer Drug Research with Big Pharma